Mild hypercortisolism couldmodulate the tumor microenvironment, and it is already observed that glucocorticoid receptor activation on specific hormone-dependent tumor entities (breast and prostate cancer) can inhibit tumor cell growth and proliferation [20,21]. The gene discussed is NR3C1; the disease is Familial prostate cancer.